A randomized Phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib maintenance (PC/G) with gefitinib monotherapy (G) in East Asian patients (pts) with locally advanced or metastatic nonsquamous non-small cell lung cancer (nSqNSCLC): Final survival results.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 8041-8041 ◽  
Author(s):  
James Chih-Hsin Yang ◽  
Vichien Srimuninnimit ◽  
Myung-Ju Ahn ◽  
Chia-Chi Lin ◽  
Sang-We Kim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
East Asian ◽  
Locally Advanced ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Phase 3 ◽  
Asian Patients ◽  
Final Survival ◽  
East Asian Patients

scholarly journals P70.01 Distribution of CCND1 Mutations in East Asian Patients With Non-Small Cell Lung Cancer

2021 ◽  
Vol 16 (3) ◽  
pp. S562-S563
Author(s):  
H. Feng ◽  
C. Xu ◽  
W. Wang ◽  
D. Wang ◽  
Y. Zhu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
East Asian ◽  
Small Cell ◽  
Small Cell Lung ◽  
Asian Patients ◽  
East Asian Patients

P70.09 NOTCH1 Mutations in East Asian Patients With Non-Small-Cell Lung Cancer

2021 ◽  
Vol 16 (10) ◽  
pp. S1214
Author(s):  
B. Song ◽  
C. Xu ◽  
W. Wang ◽  
D. Wang ◽  
Y. Zhu ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
East Asian ◽  
Small Cell ◽  
Small Cell Lung ◽  
Asian Patients ◽  
Notch1 Mutations ◽  
East Asian Patients
Sign in / Sign up

Export Citation Format

Share Document